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Chemo-Enzymatic Synthesis of Chiral
Fluorine-Containing Building Blocks
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Quirinus B. Broxtermanc, and Hans E. Schoemakerc
Abstract: Two complementary strategies for the synthesis of optically active fluorine-containing building
blocks have been probed. The first strategy involves either the enzymatic resolution of fluorinated α,α-di-
substituted-α-amino acid amides, or the asymmetric hydrogenation of fluorinated dehydroamino acids. The
second strategy involves the transition metal-catalyzed introduction of fluorine-containing substituents onto
olefin- or acetylene-containing α-H-α-amino acids. These amino acids in turn are made optically active by
enzymatic resolution of the corresponding amides.
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Introduction
The facile stereospecific synthesis of a
variety of multifunctional building blocks
is an important component of the drug dis-
covery toolbox. More specifically, technol-
ogy for the preparation of fluorine-contain-
ing building blocks forms a powerful addi-
tion to this toolbox. To this end, Chiralix
aims at the development of novel technolo-
gies for the efficient synthesis of such chi-
ral, densely functionalized compounds by a
synergistic combination of advanced organ-
ic synthesis, homogeneous transition metal
catalysis, and biocatalysis. This is done in
close collaboration with the academic re-
search group of Prof. Floris Rutjes at the
University of Nijmegen (NL), as well as
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This paper describes some of the recent
efforts of Chiralix and its partners in the de-
velopment of novel methodologies for the
chemo-enzymatic preparation of chiral flu-
orine-containing building blocks.
Two Complementary Approaches
In order to arrive at the desired chiral
fluorinated compounds we envisaged two
possible strategies, depicted in Fig. 1, either
one of which should give access to both
enantiomerically pure forms of a given
building block. The first strategy (counter-
clockwise in Fig. 1) would be to introduce
the desired fluorinated group(s) into a
racemic or prochiral substrate, followed by
an asymmetric transformation to obtain the
molecule in enantiomerically pure form.
The second strategy involves the asymmet-
ric transformation of a non-fluorinated
building block and subsequent installation
of the fluorinated group(s) onto the enan-
tiomerically pure material.
In principle, these two strategies are
complementary since they enable us to
choose whether the fluorous substituent
should be introduced prior to or during the
diversification process. Depending on the
substitution pattern and complexity of the
desired building block, one of the two
strategies could prove most advantageous
and we therefore set out to probe both path-
ways.
The First Strategy
One of our core chiral competences is
the enzymatic resolution of amino acid
amides by hydrolytic enzyme systems (Fig.
2). In general, these enzymes convert L-
amino acid amides to the corresponding L-
amino acids, while leaving the D-amino
acid amides untouched. Over the last few
years a set of microorganisms containing
highly stereoselective aminopeptidases and
amidases have been identified, all exhibit-
ing their own specific substrate tolerance
[1]. The aminopeptidase present in
Pseudomonas putida ATCC 12633 was
shown to give excellent results in the hy-
drolysis of α-H-α-amino acid amides, with
a wide variety of amino acid side chains [2].
For the resolution of α,α-disubstituted-α-
amino acid amides, whole cells of My-
cobacterium neoaurum proved to be the
biocatalyst of choice [3], whereas
Ochrobactrum anthropi whole cells could
be applied in a whole range of resolutions,
including those of α-H-α-hydroxy car-
boxylic acids [4].
In collaboration with the group of Prof.
Burger in Leipzig (Germany) a resolution
protocol was developed for fluorinated
α,α-disubstituted-α-amino acid amides,
using the amidase from Mycobacterium
neoaurum. As can be seen from the results
of these enzymatic conversions depicted in
Table 1, the enzyme performed very well
with the three substrates that were investi-
gated. The astonishing discriminatory pow-
er of the amidase becomes evident from the
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striking result with the α-methyl-α-trifluo-
romethyl substituted amide (entry 1), where
the enzyme is able to distinguish perfectly
between two sterically very similar sub-
stituents. Upon facile separation of the (R)-
acid and the remaining (S)-amide, followed
by chemical hydrolysis of the amide, also the
(S)-amino acid was obtained (ee >99%). The
functional groups present in such α,α-disub-
stituted amino acids offer ample opportuni-
ties for further diversification.
A totally different approach to target
enantiomerically pure fluorinated amino
acids is the asymmetric hydrogenation of
dehydroamino acid derivatives [5]. Excel-
lent results in the rhodium-catalyzed prepa-
ration of amino acid derivatives were ob-
tained by using MonoPhos (Scheme 1), a
novel proprietary monodentate ligand de-
veloped by the group of Prof. Ben Feringa
(University of Groningen, The Nether-
lands) [6]. This air and moisture stable
phosphoramidite ligand can be synthesized
in a single step from cheap commercially
available materials and is an order of mag-
nitude cheaper than currently available bis-
phosphine ligands. For the preparation of
the required dehydrophenylalanine sub-
strates for the asymmetric hydrogenation
reactions, Heck couplings between fluo-
rine-substituted arylbromides and methyl
2-acetylaminoacrylate were employed
(Scheme 2). Interestingly, these reactions
could be performed with very low catalyst
loadings, i.e. down to 0.05 mol%, and only
afforded the Z-isomers of the products.
When conducting the asymmetric hydro-
genation experiments, it was gratifying to
find that the rhodium-MonoPhos complex
performed generally well, as can be seen
from the results depicted in Table 2. In all
cases the reactions proceeded with high
enantioselectivities and the products were
obtained in quantitative yields.
With these results in hand we now
turned our attention to the second strategy,
in which first the enantiomerically pure
building blocks were prepared and subse-
quently fluorine-containing substituents
were introduced.
The Second Strategy
The preparation of the required enan-
tiomerically pure building blocks again was
based on the enzymatic resolution of amino
acid amides, in this case non-fluorinated α-
H-α-amino acid amides. It had already
been shown that the aminopeptidase pres-
ent in Pseudomonas putida could be used
very effectively for the resolution of such
amino acids (vide supra). The enzyme
proved to be tolerant to a wide variety of
amino acid amides, including those with
unsaturated side-chains such as olefins,
acetylenes and allenes [7]. Since such un-
saturations allow various transition metal-
catalyzed functionalizations, we envisaged
to use these handles for the introduction of
the fluorinated substituents.
In literature, the palladium-catalyzed
introduction of fluoroalkyl chains onto
alkenes has been demonstrated [8]. How-
ever, the olefins used were all rather simple
and did not contain the intrinsic dense func-
tionalization of unsaturated amino acids.
Therefore, we decided to investigate the re-
action circumstances, in order to determine
whether these conditions were tolerant to
the functional groups present in the amino
acid substrates. As can be seen from the re-
sults depicted in Table 3, a variety of fluo-
roalkyl chains could be successfully intro-
duced via this method. Everything from
Fig 1. Two complementary strategies for the preparation of enantiomerically pure fluorine-con-
taining building blocks
Fig 2. A broad range of amino acid amides can be efficiently hydrolyzed with excellent enan-
tioselectivity by three different microorganisms
Table 1. Enzymatic resolutions of fluorinated α,α-disubstituted-α-amino acid amides
Entry X Conversion ee (R)-acid ee (S)-amide E value
1 F 50% 96% >99% >183
2 Cl 51% 95% >99.5% >200
3 Br 51% 95% >99.5% >200
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perfluoro-iso-propyl iodide to perfluoro-
octyl iodide reacted smoothly to give the
anticipated fluorinated products (entries
15). However, the use of trifluoromethyl
iodide resulted in a very poor conversion
and only afforded the product in a low
yield. Even more disappointing was the at-
tempt with perfluoro-tert-butyl iodide,
which did not give rise to the expected
product at all. Nonetheless, the fluorinated
products that had been formed could be
successfully de-iodinated, via hydrogena-
tion over palladium on carbon, as exempli-
fied in Scheme 3.
Another literature example of the intro-
duction of fluorinated chains onto unsatu-
rated moieties, involved the zinc-catalyzed
addition of perfluoroalkyl iodides onto
acetylenes [9]. Again this example involved
only relatively unfunctionalized acetylenes,
thus we studied the utility of this method in
the case of our amino acid substrates. Grat-
ifyingly, the reaction between perfluo-
robutyl iodide and a suitably protected
propargylglycine derivative, mediated by a
catalytic amount of zinc powder and a cat-
alytic amount of trifluoroacetic acid, pro-
ceeded very smoothly to give the fluorinat-
ed olefinic product in a good yield (Scheme
4). The vinyl iodide moiety that results
from this reaction provides a convenient
handle for further derivatization, since it
can be used in a multitude of transition
metal-catalyzed cross coupling reactions.
Conclusions
We have demonstrated two complemen-
tary strategies for the synthesis of optically
Scheme 1. Rhodium-catalyzed asymmetric
hydrogenations using MonoPhos
Scheme 2. Preparation of dehydrophenyl-
alanine substrates via Heck reactions
Table 2. Preparation of fluorinated phenylalanine derivatives via asymmetric hydrogenation
Entry R F-position Time [min.] ee
1 H 2 25 95% 
2 H 3 30 95%
3 H 4 15 95%
4 3-NO2 4 120 95%
5 4-Ph 3 25 93%
Table 3. Palladium-catalyzed addition of fluoroalkyl chains onto olefinic amino acids
Entry CnF2n+1l Yield
1 iso-C3F7l 90% 
2 C4F9l 92%
3 C6F13l 96%
4 C6F17l 96%
5 CF3l 10%
6 tert-C4F9l 0%
FLUORINE IN THE LIFE SCIENCE INDUSTRY 107
CHIMIA 2004, 58, No. 3
active fluorine-containing building blocks.
The first strategy involves either the enzy-
matic resolution of fluorinated α,α-disub-
stituted-α-amino acid amides, or the asym-
metric hydrogenation of fluorinated de-
hydroamino acids. The second strategy
involves the transition metal-catalyzed in-
troduction of fluorine-containing sub-
stituents onto enantiomerically pure unsat-
urated α-H-α-amino acids, which in turn
can be prepared by enzymatic resolution of
the corresponding amides. Palladium cata-
lysis allows the introduction of fluoroalkyl
chains onto olefinic amino acids, whereas
acetylenic amino acids can be fluoroalky-
lated by means of zinc catalysis.
The two complementary strategies al-
low maximum flexibility, since they enable
the strategic choice, whether the fluorous
substituent should be introduced prior to or
during the diversification process. Depend-
ing on the substitution pattern and com-
plexity of the desired building block, one of
the two approaches could prove most ad-
vantageous.
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